Amanda Morris
Family · Leawood, KSNPI 1548622590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 298 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,489 and has fallen 60.9% since, to $583 in 2025. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 298 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$596
- Abbott$299
- Novo Nordisk$286
- Amgen$211
- AstraZeneca$207
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,816100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $1,085 |
| Lilly USA, LLC | 33 | $596 |
| Abbott | 17 | $299 |
| Novo Nordisk | 23 | $286 |
| Amgen | 11 | $211 |
| AstraZeneca | 12 | $207 |
| Merz North America, Inc. | 2 | $199 |
| Pfizer | 10 | $184 |
| Biohaven Pharmaceutical Holding Company Ltd. | 22 | $183 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $146 |
| Merck | 8 | $139 |
| Antares Pharma, Inc. | 8 | $138 |
| Rhythm Pharmaceuticals, Inc. | 2 | $131 |
| Axsome Therapeutics, Inc. | 5 | $104 |
| Novartis | 5 | $101 |
| Biohaven Pharmaceuticals, Inc. | 4 | $78 |
| Boehringer Ingelheim | 4 | $74 |
| Amarin Pharma, Inc. | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $60 |
| Clarus Therapeutics Inc. | 5 | $58 |
| Astellas Pharma US Inc | 3 | $57 |
| Bayer | 3 | $54 |
| Tolmar, Inc. | 3 | $48 |
| Johnson & Johnson | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Upsher-smith Laboratories LLC | 1 | $25 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Vertex | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Exeltis, USA Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Biogen | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,816 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Other family in Leawood
- Amanda CaldwellLeawood$203K
- Amy AvantLeawood$10K
- Jessica MolstadLeawood$8K
- Robyn MooreLeawood$7K
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.